Gonadorelin, a synthetic decapeptide, functions as a gonadotropin-releasing hormone (GnRH) agonist. Comprising ten amino acids joined in sequence, including pyroglutamyl, histidyl, and glycinamide residues, it is synthesized using solid-phase peptide synthesis. Gonadorelin plays a pivotal role in stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. Acting through transmembrane LHRH receptors on pituitary gonadotropic cells, gonadorelin triggers gonadotropin secretion. However, continuous administration induces desensitization, exerting a negative feedback effect. Clinically, gonadorelin is utilized to manage hypothalamic amenorrhea and to evaluate hypothalamic or pituitary function, reflecting its versatility as a hormone therapy agent.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem